Phendimetrazine
Phendimetrazine is a prescription stimulant used as a short-term aid for weight loss in adults with obesity who haven't responded to diet and exercise alone.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 17 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Phendimetrazine: Patient Information Guide
A plain-language walkthrough of Phendimetrazine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Phendimetrazine tartrate is a prescription weight-loss aid approved for short-term use in adults with obesity. Here is what the available products are approved for:
- Phendimetrazine Tartrate extended-release capsules are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher when additional risk factors like high blood pressure, diabetes, or high cholesterol (hyperlipidemia) are present, who have not responded adequately to diet and exercise alone.
- Phendimetrazine Tartrate tablets are indicated for adults with a BMI of 30 or higher who have not responded to diet and/or exercise alone.
- Both forms are approved only as a short-term addition (a few weeks) to a calorie-restricted diet — not as a standalone solution.
- Both forms are approved for use as monotherapy only — they must never be combined with other weight-loss drugs or stimulants.
⚙️How it works▾
Phendimetrazine is a sympathomimetic amine — a stimulant that mimics the effects of adrenaline-like chemicals in the body. It acts on the central nervous system similarly to amphetamines. It belongs to a class of drugs called anorectics, which are thought to reduce appetite, though the exact mechanism behind its weight-loss effect isn't fully established. Other actions on the brain or metabolism may also contribute.
The drug raises blood pressure and can increase heart rate as part of its stimulant effect. Tolerance to its appetite-suppressing action tends to develop within a few weeks, which is why it's only intended for short-term use.
💊How it's taken▾
Phendimetrazine tartrate comes in two oral forms with different dosing schedules — do not interchange them without your prescriber's guidance.
- Tablets: Generally taken two to three times a day, about one hour before meals. Your prescriber will adjust the dose to find what works best for you.
- Extended-release capsules (Phendimetrazine Tartrate): Taken once in the morning, 30 to 60 minutes before the morning meal. Do not take it later in the day, as it can disrupt sleep.
Always follow your prescriber's exact instructions. If you feel the medication is no longer working, do not increase your dose — talk to your doctor instead.
🤒Side effects — in detail▾
Like all stimulant medications, phendimetrazine can cause a range of side effects. Common ones include:
- Dry mouth
- Trouble sleeping (insomnia)
- Restlessness, agitation, or overstimulation
- Rapid or pounding heartbeat (palpitations or tachycardia)
- Elevated blood pressure
- Dizziness, tremor, or headache
- Nausea, stomach pain, diarrhea, or constipation
- Sweating, flushing, or blurred vision
- Urinary frequency or changes in libido
More serious reactions — including pulmonary hypertension (high pressure in the lung arteries), heart valve problems, psychosis, and severe withdrawal after stopping suddenly — require immediate medical attention. Contact your doctor or seek emergency care if you notice chest pain, shortness of breath, fainting, leg swelling, hallucinations, or extreme mood changes.
⚠️Warnings & precautions▾
- Pulmonary hypertension risk: Use of phendimetrazine has been linked to pulmonary hypertension — a rare but often fatal condition. The risk is significantly higher with more than three months of use. Stop taking it and see your doctor immediately if you develop shortness of breath during activity, chest pain, fainting, or leg swelling.
- Heart valve concerns: Some anorectic drugs have been associated with heart valve damage. While no cases have been reported with phendimetrazine used alone, your doctor may recommend a cardiac evaluation before and during treatment.
- Abuse and dependence potential: This medication is a stimulant with real potential for misuse. Do not take more than prescribed, and do not use it if you have a history of drug abuse.
- Withdrawal: Stopping suddenly after prolonged high-dose use can cause severe fatigue and depression. Talk to your doctor before stopping.
- Impaired alertness: Phendimetrazine can affect your ability to drive or operate machinery safely — be cautious until you know how it affects you.
- Short-term use only: If you haven't lost at least 4 pounds after 4 weeks, your doctor should reassess whether to continue treatment.
🔀What it interacts with▾
Phendimetrazine interacts with several drugs and substances — always give your prescriber and pharmacist a full list of everything you take.
- MAO inhibitors (e.g., phenelzine, tranylcypromine): Combining these with phendimetrazine can trigger a hypertensive crisis — a dangerous, potentially life-threatening spike in blood pressure. Do not take phendimetrazine within 14 days of stopping an MAO inhibitor.
- Alcohol: Drinking alcohol while on phendimetrazine can cause an adverse reaction — avoid it.
- Insulin and oral diabetes medications: Your need for diabetes medication may change while on phendimetrazine — monitor your blood sugar closely and tell your doctor.
- Adrenergic neuron blocking drugs (some blood pressure medications): Phendimetrazine can reduce their blood-pressure-lowering effect, potentially making your blood pressure harder to control.
- Other weight-loss drugs, stimulants, or herbal diet products: Combining these with phendimetrazine is contraindicated and increases the risk of serious side effects.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take phendimetrazine if you have a history of heart disease, coronary artery disease, stroke, heart failure, arrhythmias (abnormal heart rhythms), uncontrolled high blood pressure, or pulmonary hypertension.
- Do not take it if you have glaucoma (increased eye pressure), an overactive thyroid (hyperthyroidism), or agitated states.
- Do not take it if you have a history of drug abuse — this medication has abuse potential.
- Do not take it if you are pregnant or breastfeeding.
- Tell your doctor if you have a known heart murmur or valvular heart disease — phendimetrazine is not recommended in these cases.
- Tell your doctor if you have diabetes — your insulin or oral medication needs may change.
- Do not use phendimetrazine if you have taken any other anorectic (weight-loss) drug within the past year.
- Tell your doctor about all medications you take — prescription, over-the-counter, and herbal — before starting phendimetrazine.
🚑If you take too much▾
Taking too much phendimetrazine can cause serious symptoms, including extreme restlessness, confusion, hallucinations, panic, rapid or irregular heartbeat, very high or very low blood pressure, nausea, vomiting, seizures, coma, and in severe cases, death. If you suspect an overdose, call 911 or Poison Control (1-800-222-1222 in the US) immediately.
📡Pharmacodynamics — effects in the body▾
Phendimetrazine stimulates the central nervous system and raises blood pressure, acting similarly to amphetamines. It is classified as an anorectic — a drug that reduces appetite — though appetite suppression may not be its only weight-loss mechanism. It can also cause rapid heart rate (tachycardia). Tolerance to its appetite-reducing effect typically develops within a few weeks of regular use.
🔬Pharmacokinetics — how your body processes it▾
Phendimetrazine is eliminated mainly through the kidneys, with most of the drug and its breakdown products excreted in urine. It is partially metabolized into phenmetrazine and phendimetrazine-N-oxide. The average elimination half-life — the time it takes the body to clear half the drug — is about 3.7 hours for both the tablet and extended-release capsule forms. The tablet is absorbed more quickly than the extended-release capsule, which releases the drug gradually over time.
📄 Written from Phendimetrazine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Phendimetrazine
17 supplements and herbal products have documented interactions with Phendimetrazine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Phendimetrazine — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is phendimetrazine supposed to do for me? ▾
How do I take it — does it matter when during the day? ▾
What side effects should I expect, and which ones should make me call my doctor? ▾
Is this medication habit-forming? Can I get addicted? ▾
Can I take my other medications or supplements while on phendimetrazine? ▾
Can I take this if I'm pregnant or trying to get pregnant? ▾
Is Phendimetrazine available over the counter? ▾
Is Phendimetrazine a controlled substance? ▾
When was Phendimetrazine first available? ▾
Who makes Phendimetrazine? ▾
💬 Answers drafted from Phendimetrazine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Phendimetrazine comes
Phendimetrazine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Phendimetrazine Tartrate tablets are used as a short-term aid for weight loss in adults with a BMI of 30 or higher who have not responded to diet and exercise alone.
- Phendimetrazine Tartrate tablets are approved for use as monotherapy only — not to be combined with other weight-loss agents or stimulants.
- Phendimetrazine Tartrate tablets are generally taken two to three times a day, about one hour before meals.
- Your prescriber may start you on a lower dose to find the amount that works best for you — follow their guidance.
- Do not exceed the maximum number of tablets per day as directed by your prescriber.
- Take Phendimetrazine Tartrate tablets at the times prescribed and do not double up if you miss a dose.
Extended-release capsule
How this form is used
- Phendimetrazine Tartrate extended-release capsules are used as a short-term aid for weight loss in adults with a BMI of 30 or higher, or 27 or higher with risk factors such as high blood pressure, diabetes, or high cholesterol.
- Phendimetrazine Tartrate extended-release capsules are approved for use as monotherapy only — not combined with other weight-loss drugs.
- Phendimetrazine Tartrate extended-release capsules are taken once in the morning, 30 to 60 minutes before the morning meal.
- Phendimetrazine Tartrate extended-release capsules should not be taken later in the day to avoid sleep problems.
- Take only one extended-release capsule per day — do not take more than prescribed.
- Follow your prescriber's directions exactly; do not adjust the dose on your own.
📊 Phendimetrazine across the U.S. market
How Phendimetrazine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (2) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Phendimetrazine is used
A general measure of how commonly Phendimetrazine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Phendimetrazine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Phendimetrazine prescribed? Of the 1,596 medications we measure, Phendimetrazine ranks #1,366 by Medicaid prescriptions — more than 14% of them.
Utilization by Phendimetrazine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
phendimetrazine tartrate 35 MG Oral Tablet Most dispensed
Summed across the 2 of 178 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 979549
24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule
Summed across the 1 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 979543
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Phendimetrazine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 196 listed Phendimetrazine NDCs with Medicaid activity.
🔍 Compare Phendimetrazine products
A representative set of FDA-listed product records for Phendimetrazine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release capsule | ||||
| 105 mg | Oral | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 105 mg | Oral | Acertis Pharmaceuticals, LLC × 3 listings | NDA | View NDC → |
| 105 mg | Oral | Eon Labs, Inc. | NDA | Find on DailyMed ↗ |
| 105 mg | Oral | NuCare Pharmaceuticals, Inc. | NDA | Find on DailyMed ↗ |
| 105 mg | Oral | Virtus Pharmaceuticals, LLC | NDA | View NDC → |
| 💊Tablet | ||||
| 35 mg | Oral | A-S Medication Solutions × 11 listings | ANDA | View NDC → |
| 35 mg | Oral | Bryant Ranch Prepack × 15 listings | ANDA | View NDC → |
| 35 mg | Oral | Calvin Scott & Co., Inc. × 2 listings | ANDA | View NDC → |
| 35 mg | Oral | Elite Laboratories, Inc | ANDA | View NDC → |
| 35 mg | Oral | Eon Labs, Inc. | ANDA | View NDC → |
| 35 mg | Oral | Kvk-tech, Inc × 6 listings | ANDA | View NDC → |
| 35 mg | Oral | Northwind Pharmaceuticals | ANDA | Find on DailyMed ↗ |
| 35 mg | Oral | NuCare Pharmaceuticals, Inc, × 2 listings | ANDA | View NDC → |
| 35 mg | Oral | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 35 mg | Oral | NuCare Pharmaceuticals,Inc. × 4 listings | ANDA | View NDC → |
| 35 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 35 mg | Oral | Preferred Pharmaceuticals Inc. × 4 listings | ANDA | View NDC → |
| 35 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 35 mg | Oral | Virtus Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Olon SpA | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
Showing 65 of 65 products — FDA National Drug Code Directory. See every product, package size and price: browse all 65 Phendimetrazine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Phendimetrazine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Phendimetrazine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Phendimetrazine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 33272 2 dose forms · 2 strengths
-
Dose form (SCDF) Extended Release Oral Capsule RxCUI 373305In current FDA listingsClinical drug / strength (SCD) 24 HR phendimetrazine tartrate 105 MGRxCUI 979543 -
Dose form (SCDF) Oral Tablet RxCUI 373306In current FDA listingsClinical drug / strength (SCD) tartrate 35 MGRxCUI 979549
Look up RxCUI 33272 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Phendimetrazine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Phendimetrazine belongs to the Sympathomimetic Amine Anorectic class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 17 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Acertis Pharmaceuticals, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.